Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Lupus Erythematosus, Lupus Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableLooking for participantsNCT07666711
What this trial is testing

Biomarker Development for Autoimmune Disorders Involving the Kidneys

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Oslo University Hospital 500
Testing effectiveness (Phase 2)WithdrawnNCT04883619
What this trial is testing

Nipocalimab in Adult Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC
Post-approval studies (Phase 4)Not Yet RecruitingNCT07035834
What this trial is testing

SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis

Who this might be right for
Lupus Nephritis (LN)ANCA Associated Vasculitis (AAV)
Federico II University 40
Testing effectiveness (Phase 2)Study completedNCT03200002
What this trial is testing

Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis

Who this might be right for
To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients
Chitwan Medical College 49
Early research (Phase 1)Study completedNCT06064929
What this trial is testing

Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Who this might be right for
Lupus Nephritis
HI-Bio, A Biogen Company 14
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Not applicableStudy completedNCT00342329
What this trial is testing

Lupus Nephritis: Role of Environmental and Occupational Exposures

Who this might be right for
Lupus Nephritis
National Institute of Environmental Health Sciences (NIEHS)
Large-scale testing (Phase 3)Study completedNCT00429377
What this trial is testing

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

Who this might be right for
Lupus Nephritis
Astellas Pharma Inc 64
Early research (Phase 1)Study completedNCT00046774
What this trial is testing

Monoclonal Antibody Treatment for Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 23
Testing effectiveness (Phase 2)Study completedNCT02547922
What this trial is testing

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 147
Post-approval studies (Phase 4)Ended earlyNCT01316133
What this trial is testing

Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Astellas Pharma Korea, Inc. 37
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Study completedNCT02550652
What this trial is testing

Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 126
Not applicableLooking for participantsNCT07575347
What this trial is testing

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Who this might be right for
Periodontal DiseasePeriodontitisCKD+6 more
Stefan Lujinschi 100
Large-scale testing (Phase 3)Looking for participantsNCT06711887
What this trial is testing

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 348
Testing effectiveness (Phase 2)UnknownNCT00569101
What this trial is testing

A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Seoul National University Hospital 9
Not applicableStudy completedNCT00298506
What this trial is testing

Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 120
Large-scale testing (Phase 3)Ended earlyNCT02514967
What this trial is testing

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 3
Next Page